Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea.
Urology. 2012 Jun;79(6):1379-84. doi: 10.1016/j.urology.2012.02.010. Epub 2012 Apr 13.
To survey cases of benign prostatic hyperplasia (BPH) among patients visiting urologists with lower urinary tract symptoms (LUTS) at general hospitals in Korea and to investigate treatment outcomes in current clinical practice.
This was a multicenter, prospective study conducted in 18 urology centers in Korea. The symptoms of BPH were observed via the International Prostate Symptoms Score (IPSS), transrectal ultrasonography, uroflometry, prostate, specific, antigen, PSA) and postvoid residual volume at the baseline, 1 week, 4 weeks, 12 weeks, 24 weeks, and 52 weeks after initial evaluation. The patients were divided into three groups according to age (group I: 50-59; group II: 60-69; group III: 70 years or older).
Of the 1054 screened men, 966 were enrolled and 917 were diagnosed with BPH. Total IPSS and storage subscores were significantly higher in group III than in group II or I. By month 12, significant improvements on total IPSS and voiding subscores were demonstrated in group I over groups II and III (P = .02. 03, respectively). The incidence of dual combination therapy was significantly higher in the patients whose prostate volume was ≥30 mL and whose PSA was ≥1.5.
At the initial visit, patients with LUTS/BPH, especially those who were relatively young, visited urologic centers because of to voiding symptoms rather than storage symptoms. In contrast, elderly men who visited the urologic centers complained not only of voiding symptoms but also storage symptoms. However, at 12 months' follow up, all of the age groups showed improvement in both storage and voiding symptoms.
调查韩国综合医院泌尿科就诊的下尿路症状(LUTS)患者中良性前列腺增生(BPH)的病例,并研究当前临床实践中的治疗效果。
这是一项在韩国 18 个泌尿科中心进行的多中心前瞻性研究。BPH 的症状通过国际前列腺症状评分(IPSS)、经直肠超声、尿流率、前列腺特异性抗原(PSA)和残余尿量在基线、1 周、4 周、12 周、24 周和 52 周时进行观察。患者根据年龄分为三组(I 组:50-59 岁;II 组:60-69 岁;III 组:70 岁或以上)。
在筛选的 1054 名男性中,有 966 名被纳入研究,其中 917 名被诊断为 BPH。III 组的总 IPSS 和储存子评分明显高于 II 组或 I 组。在第 12 个月时,I 组的总 IPSS 和排尿子评分较 II 组和 III 组有显著改善(P =.02.03)。前列腺体积≥30ml 和 PSA≥1.5 的患者联合使用双重药物治疗的发生率明显较高。
在初诊时,患有 LUTS/BPH 的患者,尤其是那些相对年轻的患者,因为排尿症状而不是储存症状就诊于泌尿科中心。相比之下,就诊于泌尿科中心的老年男性不仅抱怨排尿症状,还抱怨储存症状。然而,在 12 个月的随访中,所有年龄组的储存和排尿症状都有所改善。